Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Notice for dordaviprone (Biointelect Pty Ltd)
Active ingredients
dordaviprone
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
For the treatment of glioma
Therapeutic area
Oncology